Nanomedicines, including polymer nanocarriers with controlled drug release, are considered next-generation therapeutics with advanced therapeutic properties and reduced side effects. To develop safe and efficient nanomedicines, it is crucial to precisely determine the drug release kinetics.
Herein, we present application of analytical methods, i.e., surface plasmon resonance biosensor technology (SPR), capillary electrophoresis, and (1)H diffusion-ordered nuclear magnetic resonance spectroscopy, which were innovatively applied for drug release determination. The methods were optimised to quantify the pH-triggered release of three structurally different drugs from a polymer carrier.
The suitability of these methods for drug release characterisation was evaluated and compared using several parameters including applicability for diverse samples, the biological relevance of the experimental setup, method complexity, and the analysis outcome. The SPR method was the most universal method for the evaluation of diverse drug molecule release allowing continuous observation in the flow-through setting and requiring a small amount of sample.
High-performance liquid chromatography is widely used to characterise pH-triggered drug release from nanomaterials, but is limited by the specific physicochemical properties of the analytes. Here, the authors investigate the application of surface plasmon resonance biosensing, nuclear magnetic resonance spectroscopy, and capillary electrophoresis to evaluate the release kinetics of diverse drugs from a polymeric drug delivery system.